Most bought healthcare stocks in Q2 2025
See which Healthcare stocks institutional investors increased the most in Q2 2025, measured as net growth in reported share positions from Q1 2025 into Q2 2025. Notable additions at the top of this list include UNITEDHEALTH GROUP INC (UNH), AVANTOR INC (AVTR), DANAHER CORP (DHR), EVOLENT HEALTH INC - A (EVH). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 14,860,243 | $1.48B | 9 | 17 | 14 | 8 | 48 |
| AVTR | AVANTOR INC | 14,388,571 | -$95.71M | 2 | 4 | 1 | 2 | 9 |
| DHR | DANAHER CORP | 8,552,921 | $1.63B | 3 | 10 | 2 | 3 | 22 |
| EVH | EVOLENT HEALTH INC - A | 7,015,765 | $88.42M | 2 | 1 | 0 | 1 | 3 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 6,756,473 | $378.60M | 0 | 7 | 4 | 3 | 14 |
| OPCH | OPTION CARE HEALTH INC | 4,785,417 | $143.81M | 0 | 3 | 0 | 1 | 3 |
| BSX | BOSTON SCIENTIFIC CORP | 3,786,861 | $447.99M | 2 | 8 | 5 | 2 | 17 |
| SGMO | SANGAMO THERAPEUTICS INC | 3,671,327 | $1.62M | 0 | 1 | 0 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | 3,573,724 | $272.13M | 1 | 5 | 8 | 1 | 16 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,561,829 | -$278.78M | 0 | 7 | 1 | 1 | 8 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 2,467,915 | -$254.98M | 0 | 9 | 7 | 0 | 16 |
| BLCO | BAUSCH + LOMB CORP | 2,458,245 | $26.67M | 1 | 0 | 0 | 1 | 2 |
| MRSN | MERSANA THERAPEUTICS INC | 2,010,275 | $554.56K | 0 | 1 | 0 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,922,165 | $18.17M | 0 | 2 | 0 | 0 | 2 |
| HUM | HUMANA INC | 1,921,204 | $107.30M | 1 | 7 | 3 | 1 | 11 |
| TXG | 10X GENOMICS INC-CLASS A | 1,763,784 | $59.61M | 0 | 3 | 0 | 2 | 4 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,505,507 | -$3.06M | 2 | 1 | 0 | 0 | 3 |
| GH | GUARDANT HEALTH INC | 1,487,395 | $96.55M | 2 | 2 | 1 | 0 | 6 |
| REGN | REGENERON PHARMACEUTICALS | 1,460,987 | $463.36M | 2 | 5 | 6 | 4 | 13 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 1,417,228 | $566.35M | 2 | 6 | 7 | 0 | 18 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,169,564 | $72.45M | 1 | 6 | 1 | 0 | 9 |
| GOSS | GOSSAMER BIO INC | 1,163,139 | $1.65M | 0 | 1 | 0 | 0 | 2 |
| ARVN | ARVINAS INC | 1,082,055 | $8.01M | 0 | 1 | 0 | 0 | 2 |
| OVID | OVID THERAPEUTICS INC | 1,071,509 | $371.92K | 0 | 1 | 0 | 0 | 1 |
| GSK | GSK PLC-SPON ADR | 1,062,498 | $12.84M | 3 | 7 | 5 | 1 | 15 |
| BIO | BIO-RAD LABORATORIES-A | 1,032,608 | $242.61M | 0 | 2 | 4 | 1 | 6 |
| EXEL | EXELIXIS INC | 1,021,347 | $151.99M | 2 | 5 | 1 | 1 | 8 |
| COR | CENCORA INC | 954,308 | $318.84M | 3 | 3 | 3 | 4 | 11 |
| BAX | BAXTER INTERNATIONAL INC | 922,367 | -$341.60M | 0 | 7 | 7 | 3 | 15 |
| XRAY | DENTSPLY SIRONA INC | 920,065 | $28.60M | 1 | 3 | 1 | 1 | 6 |
| CCCC | C4 THERAPEUTICS INC | 878,688 | $1.22M | 0 | 1 | 0 | 0 | 1 |
| VERV | VERVE THERAPEUTICS INC | 878,465 | $11.07M | 1 | 1 | 0 | 0 | 2 |
| CPRX | CATALYST PHARMACEUTICALS INC | 840,180 | $5.04M | 0 | 2 | 2 | 0 | 5 |
| IPSC | CENTURY THERAPEUTICS INC | 837,182 | $565.76K | 0 | 1 | 0 | 0 | 1 |
| MASI | MASIMO CORP | 816,082 | $139.16M | 1 | 2 | 0 | 0 | 5 |
| IDXX | IDEXX LABORATORIES INC | 812,658 | $899.63M | 1 | 7 | 6 | 3 | 16 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 802,100 | $4.72M | 1 | 1 | 0 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | 795,433 | -$103.19M | 2 | 8 | 13 | 5 | 26 |
| ABBV | ABBVIE INC | 784,322 | $58.89M | 5 | 13 | 9 | 4 | 36 |
| BKD | BROOKDALE SENIOR LIVING INC | 730,267 | $11.13M | 1 | 1 | 2 | 0 | 4 |
| CTMX | CYTOMX THERAPEUTICS INC | 706,200 | $3.49M | 0 | 1 | 0 | 0 | 1 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 703,512 | $460.88K | 0 | 1 | 0 | 0 | 1 |
| GBIO | GENERATION BIO CO | 700,110 | $64.44K | 0 | 1 | 0 | 0 | 1 |
| OABI | OMNIAB INC | 680,950 | $1.17M | 0 | 1 | 0 | 0 | 1 |
| BPMC | BLUEPRINT MEDICINES CORP | 674,023 | $87.07M | 1 | 0 | 2 | 0 | 3 |
| NTLA | INTELLIA THERAPEUTICS INC | 666,342 | $35.86M | 2 | 1 | 1 | 1 | 4 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 654,200 | $2.70M | 0 | 1 | 0 | 0 | 2 |
| IMNN | IMUNON INC | 627,558 | $499.44K | 0 | 1 | 0 | 0 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 627,346 | $10.56M | 1 | 1 | 1 | 0 | 4 |
| TCRX | TSCAN THERAPEUTICS INC | 622,350 | $914.29K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2025
What are the most bought Healthcare stocks in Q2 2025?
The most bought healthcare stocks in Q2 2025 are those with the largest increase in reported share counts across institutional investors compared to Q1 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2025?
Among filers in this sector, net additions were largest in companies such as UNITEDHEALTH GROUP INC (UNH), AVANTOR INC (AVTR), DANAHER CORP (DHR), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2025).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.